Related references
Note: Only part of the references are listed.Gender, Racial and Ethnic Differences in Pathologic Response Following Neoadjuvant Chemotherapy for Bladder Cancer Patients EDITORIAL COMMENT
Rishi R. Sekar et al.
UROLOGY (2023)
The Intensity-Modulated Pelvic Node and Bladder Radiotherapy (IMPART) Trial: A Phase II Single-Centre Prospective Study
M. P. Tan et al.
CLINICAL ONCOLOGY (2020)
PD-1/PD-L1 Immune Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects
Alexis Rompre-Brodeur et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation
Jim Zhong et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients
Toshiki Kijima et al.
BJU INTERNATIONAL (2019)
Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer
Di (maria) Jiang et al.
CLINICAL GENITOURINARY CANCER (2019)
Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
Trevor J. Royce et al.
CLINICAL GENITOURINARY CANCER (2019)
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Jason A. Efstathiou et al.
EUROPEAN UROLOGY (2019)
A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014
Dan-Olle Westergren et al.
JOURNAL OF UROLOGY (2019)
Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer
David Buchser et al.
UROLOGY (2019)
Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
Waqar Haque et al.
CLINICAL GENITOURINARY CANCER (2019)
Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)
Ricarda Merten et al.
ONCOLOGIST (2019)
Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer
Stephen B. Williams et al.
JAMA SURGERY (2019)
Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Longterm Outcomes With Dose Escalation
V Murthy et al.
CLINICAL ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Juergen E. Gschwend et al.
EUROPEAN UROLOGY (2019)
Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer
Haruhito Azuma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment
Wei Meng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712A Randomized Phase II Trial
John J. Coen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer
Elisabeth E. Fransen van de Putte et al.
JOURNAL OF UROLOGY (2019)
Impact of Facility Radiation Patient Volume on Overall Survival in Patients with Muscle Invasive Bladder Cancer Undergoing Trimodality Bladder Preservation Therapy
Benjamin W. Fischer-Valuck et al.
BLADDER CANCER (2019)
High-precision Bladder Cancer Irradiation in the Elderly: Clinical Results for a Plan-of-the-day Integrated Boost Technique with Image Guidance Using Lipiodol Markers
Alexander J. W. Beulens et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study
Adam B. Weiner et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature
Andrea Mari et al.
WORLD JOURNAL OF UROLOGY (2018)
Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiation Therapy
Hajime Tanaka et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Siamak Daneshmand et al.
JOURNAL OF UROLOGY (2018)
Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network
Tahlita C. M. Zuiverloon et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
Omar Fahmy et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
Skyler B. Johnson et al.
CURRENT ONCOLOGY REPORTS (2018)
National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging
Hong-Yiou Lin et al.
CANCER MEDICINE (2018)
90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study
Hooman Djaladat et al.
WORLD JOURNAL OF UROLOGY (2017)
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
Nicholas J. Giacalone et al.
EUROPEAN UROLOGY (2017)
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy
Ross E. Krasnow et al.
EUROPEAN UROLOGY (2017)
Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer
Catherine Thompson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)
M. Dror Michaelson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Vishal Vashistha et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Girish S. Kulkarni et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Temporal trends in perioperative morbidity for radical cystectomy using the National Surgical Quality Improvement Program database
Scott C. Johnson et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study
Friedrich-Carl von Rundstedt et al.
BLADDER CANCER (2017)
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy
Robert A. Huddart et al.
BJU INTERNATIONAL (2017)
A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients
Lingjian Yang et al.
CLINICAL CANCER RESEARCH (2017)
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2017)
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233
Timur Mitin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer
Kimberley S. Mak et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer
Shaista Hafeez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials
Orazio Caffo et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy
Simone Bertz et al.
VIRCHOWS ARCHIV (2016)
Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
Tracy L. Rose et al.
BLADDER CANCER (2016)
Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder Cancer
Georgios Gakis et al.
BLADDER CANCER (2016)
Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study
Juan Palou et al.
BJU INTERNATIONAL (2015)
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
S. Hafeez et al.
BRITISH JOURNAL OF CANCER (2015)
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
Andrew B. Sharabi et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base
Angela B. Smith et al.
BJU INTERNATIONAL (2014)
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
Guillaume Ploussard et al.
EUROPEAN UROLOGY (2014)
Clinical-Pathologic Stage Discrepancy in Bladder Cancer Patients Treated With Radical Cystectomy: Results From the National Cancer Data Base
Phillip J. Gray et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Occult Pelvic Lymph Node Involvement in Bladder Cancer: Implications for Definitive Radiation
Benjamin Goldsmith et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
Raymond H. Mak et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Intravesical Tumor Involvement of the Trigone Is Associated With Nodal Metastasis in Patients Undergoing Radical Cystectomy
Robert S. Svatek et al.
UROLOGY (2014)
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
Firas Abdollah et al.
CANCER EPIDEMIOLOGY (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Radiotherapy With or Without Chemotherapy in Muscle-invasive Bladder Cancer
Aditya Bagrodia et al.
EUROPEAN UROLOGY (2013)
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)
Robert A. Huddart et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
Timur Mitin et al.
LANCET ONCOLOGY (2013)
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer
Jens R. Laurberg et al.
BJU INTERNATIONAL (2012)
Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome
Polat Turker et al.
BJU INTERNATIONAL (2012)
Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
Jason A. Efstathiou et al.
EUROPEAN UROLOGY (2012)
Whole-Pelvis or Bladder-Only Chemoradiation for Lymph Node-Negative Invasive Bladder Cancer: Single-Institution Experience
Mutahir A. Tunio et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
QUALITY OF LIFE ASSESSMENT AFTER CONCURRENT CHEMORADIATION FOR INVASIVE BLADDER CANCER: RESULTS OF A MULTICENTER PROSPECTIVE STUDY (GETUG 97-015)
Jean-Leon Lagrange et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
Ananya Choudhury et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
Gareth Griffiths
JOURNAL OF CLINICAL ONCOLOGY (2011)
MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
Ananya Choudhury et al.
CANCER RESEARCH (2010)
Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
Peter J. Hoskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I-II RTOG Study (99-06) of Patients With Muscle-invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Donald S. Kaufman et al.
UROLOGY (2009)
Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer - A multi-institutional, long-term experience
Sisto Perdona et al.
CANCER (2008)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group
A Chakravarti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
A randomised trial of accelerated radiotherapy for localised invasive bladder cancer
A Horwich et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Fluorescence cystoscopy in the management of bladder cancer: A help for the urologist!
P Jichlinski et al.
UROLOGIA INTERNATIONALIS (2005)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy
MP Hagan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors
AL Zietman et al.
JOURNAL OF UROLOGY (2003)
HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder:: Prognostic implications
S Krüger et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer
WU Shipley et al.
UROLOGY (2002)
Share Paper
